Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe

European Journal of Cardio-thoracic Surgery

Volumn 51, Issue 3, 2017, Pages 411-420

  Pedersen, Jesper Holst ^a   Rzyman, Witold ^b   Veronesi, Giulia ^c   D'Amico, Thomas A ^d   Schil, Paul Van ^e   Molins, Laureano ^f   Massard, Gilbert ^g   Rocco, Gaetano ^h  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY OF BARCELONA   (Spain)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^h NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

CT screening; Implementation; Lung Cancer; Recommendations

Indexed keywords

ARTICLE; CANCER SCREENING; CLINICAL COMPETENCE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; EUROPE; EUROPEAN SOCIETY OF THORACIC SURGEON; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; LUNG CANCER; MEDICAL EDUCATION; MEDICAL SOCIETY; NON INVASIVE PROCEDURE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; THORACIC SURGEON; THORAX SURGERY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; MASS SCREENING; MINIMALLY INVASIVE SURGERY; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PHYSICIAN ATTITUDE; PROCEDURES; STANDARDS; X-RAY COMPUTED TOMOGRAPHY;

EARLY DETECTION OF CANCER; EUROPE; HUMANS; LUNG NEOPLASMS; MASS SCREENING; MINIMALLY INVASIVE SURGICAL PROCEDURES; PHYSICIAN'S ROLE; THORACIC SURGERY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85015229451     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezw418     Document Type: Article

References (107)

1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409
2. Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-53
3. Moyer VA. US Preventive Services Task Force. Screening for lung cancer: US Preventive services task force recommendation statement. Ann Int Med 2014;160:330-8
4. US Preventive Services Task Force. Final Recommendation Statement, Screening for Lung Cancer: US Preventive Services. http://www. uspreventi veservicestaskforce. org/Page/Document/RecommendationStatement Final/lung-cancer-screening (4 October 2016, date last accessed)
5. Description of Medicare Coverage Regarding Lung Cancer Screening. https://www. medicare. gov/coverage/lung-cancer-screening. html (4 October 2016, date last accessed)
6. Jaklitsch MT, Jacobson FL, Austin JH, Field J, Jett J, Keshavies S et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:33-8
7. Rocco G, Allen M, Altorki NK, Asamura H, Blum MG, Detterbeck F et al. Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg 2013;96:357-60
8. American Lung Association. Providing Guidance on Lung Cancer Screening to Patients and Physicians. http://www. lung. org/lung-healthand-diseases/lung-disease-lookup/lung-cancer/diagnosing-and-treat ing/lung-cancer-screening (4 October 2016, date last accessed)
9. Wood DE. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Lung Cancer Screening. Thorac Surg Clin 2015;25:185-97. NCCN clinical practice guidelines. http://www. respira tory-thessaly. gr/assets/lung_screening1. 2016. pdf (January 2016, date last accessed)
10. Wender R, Fontham ETH, Barrera E. Jr, American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-17
11. Field JK, Smith RA, Aberle DR, Ourdkerk M, Baldwin D, Yankelevitz D et al. International Association for the Study of Lung Cancer computed tomography screening workshop 2011 report. J Thorac Oncol 2012;7:10-19
12. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418-29
13. Mulshine JL, D'amico TA. Issues with implementing a high-quality lung cancer screening program. CA Cancer J Clin 2014;64:352-63
14. Zhou Q, Fan Y, Bu H, Wang Y, Wu N, Huang Y et al. China national lung cancer screening guideline with low-dose computed tomography (2015 version). Thoracic Cancer 2015;6:812-8
15. Zhao SJ, Wu N. Early detection of lung cancer: low-dose computed tomography screening in China. Thorac Cancer 2015;6:385-9
16. Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M et al. on behalf of the European Society of Radiology (ESR) and the European Respiratory Society (ERS). ESR/ERS White Paper on Lung Cancer Screening. Eur Radiol 2015;25:2519-31
17. Frauenfelder T, Puhan MA, Lazor R, von Garnier C, Bremerich J, Nieman T et al. Early detection of lung cancer: a statement from an expert panel of the Swiss University Hospitals on lung cancer screening. Respiration 2014;87:254-64
18. Vansteenkiste J, Crino L, Dooms C, Douillard JY, Faivre-Finn C, Lim E et al. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 2014;25:1462-74
19. Heuvelmans MA, Vliegenthart R, Ourdkerk M. Contributions of the European trials (European Randomized Screening Group) in computed tomography lung cancer screening. J Thorac Imaging 2015;30:101-7
20. Field JK, Devaraj A, Duffy SW, Baldwin DR. CT screening for lung cancer: is the evidence strong enough? Lung Cancer 2016;91:29-35
21. Field J, van Klaveren R, Pedersen J, Pasturino U, Paci E, Becker N et al. European randomised lung cancer screening trials: post NLST. J Surg Oncol 2013;108:280-6
22. Van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9
23. Horeweg N, van der Aalst CM, Thunnissen E, Nackaerts K, Weeninde C, Groen HJ et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013;187:848-54
24. Wille MMW, Dirksen A, Ashraf H, Saghir Z, Back K, Brodersen J et al. Results of the Randomized Danish Lung Cancer Screening Trial with focus on High-Risk Profiling. Am J Respir Crit Care Med 2016;193:542-51
25. Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weeinde C, Lammers JW et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014;15:1342-50
26. Field JK, Duffy SW, Baldwin DR, Whynes JL, Devarai A, Brain KE et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016;71:161-70
27. de-Torres JP, Wilson DO, Sanchez-Salcedo P, Weisfeld JL, Berto J, Campo A et al. Lung Cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score. Am J Respir Crit Care Med 2015;191:285-91
28. Young RP, Duan F, Chiles C, Hopkins Gamble GD, Greco EM et al. Airflow limitation and histology shift in the National Lung Screening Trial: the NLST-ACRIN cohort substudy. Am J Respir Crit Care Med 2015;192:1060-7
29. Tammemägi MC. Application of risk prediction models to lung cancer screening. A review. J Thorac Imaging 2015;30:88-100
30. Stang A, Schuler M, Kowall B, Darwiche K, Kühl H, Jöckel K. Lung cancer screening using low dose CT scanning in Germany. Extrapolation of results from the National Lung Screening Trial. Dtsch Artzbl Int 2015;112:637-44
31. http://ec. europa. eu/health/major_chronic_diseases/docs/2nd_implre port_cancer screening_co_eppac_en. pdf (4 October 2016, date last accessed)
32. Mulshine JL, Altorki N. Inplementing lung cancer screening: a checklist. Lung Cancer Management 2014;3:1-4
33. Grondin SC, Edwards JP, Rocco G. Surgeons and lung cancer screening: rules of engagement. Thorac Surg Clin 2015;25:175-84
34. Rocco R, Jones DR, Morabito A, Franco R, La Mantia E, Rocco G. Validation of the new IASLC/ATS/ERS lung adenocarcinoma classification: a surgeon's perspective. J Thorac Dis 2014;6(Suppl 5):S547-51
35. Brunelli A, Falcoz PE, D'amico T, Hansen H, Lim E, Massard G et al. European guidelines on structure and qualification of general thoracic surgery. Eur J Cardiothorac Surg 2014;45:779-86
36. Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest 2015;147:295-303
37. Lung CT. Screening Reporting and Data System (Lung-RADSTM). http:// www. acr. org/Quality-Safety/Resources/LungRADS (4 October 2016, date last accessed)
38. Fintelmann FJ, Bernheim A, Digumarthy SR. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program. pubs. rsna. org/doi/pdf/10. 1148/rg. 2015150079 (4 October 2016, date last accessed)
39. McMahon PM, Kong CY, Bouzan C, Wernstein MC, Cipriano LE, Tramontano AC et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011;6:1841-8
40. Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC et al. Cost-effectiveness of Lung Cancer Screening in Canada. JAMA Oncol 2015;1:807-13
41. Pedersen JH, Tønnesen P, Ashraf H. Smoking Cessation and Lung Cancer Screening. Ann Transl Med 2016;4:157
42. Flores R, Bauer T, Aye R, Andaz S, Kohman L, Sheppard B et al. I-ELCAP Investigators. Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer. J Thorac Cardiovasc Surg 2014;147:1619-26
43. Rzyman W, Jelitto Górska M, Dziedzic R, Biadacz I, Ksiazek J, Chwirot P et al. Diagnostic work up and surgery in participants of the Gdańsk lung cancer screening programme: the incidence of surgery for non malignant conditions. Interact CardioVasc Thorac Surg 2013;17:969-73
44. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification Of Lung Adenocarcinoma. J Thoracic Oncol 2011;6:244-85
45. Van Schil PE, Asamura H, Rusch VW, Mitsudomi T, Tsuboi M, Brambilla E et al. Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respiratory J 2012;39:478-486
46. Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177-84
47. Horeweg N, van der Aalst CM, Vliegenthart R, Zhao Y, Xie X, Scholten ET et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respiratory J 2013;42:1659-67
48. Yip R, Yankelevitz DF, Henschke CI. CT screening for lung cancer: definition of positive test result in the national lung screening trial CT cohort compared with i-elcap. J Thoracic Oncol 2013;8:S326
49. Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst 2014;106. DOI: 10. 1093/ jnci/dju284
50. Tsao AS, Scagliotti GV, Bunn Pa Jr, Carbone DP, Warren GW, Bai C et al. Scientific advances in lung cancer 2015. J Thoracic Oncology 2016;11:613-38
51. Baldwin DR, Callister MEJ. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax 2015;70:794-8
52. Herder GJ, van Tinteren H, Golding RP, Kostense PJ, Comans EF, Smit EF et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005;128:2490-6
53. Al-Ameri A, Malhotra P, Thygesen H, Plant PK, Vaidyanathan S, Karthik S et al. Risk of malignancy in pulmonary nodules: a validation study of four prediction models. Lung Cancer 2015;89:27-30
54. Ashraf H, Dirksen A, Loft A, Bertelsen AK, Bach KS, Hansen H et al. Combined use of PET scanning and Volume Doubling Time in lung cancer screening with low dose CT. Thorax 2011;66:315-9
55. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400
56. Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM, Pistolesi M, Goo JM et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266:304-17
57. McWilliams A, Tammemagi MC, Mayo JR, Roberts H, Liu G, Soghrati K et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910-19
58. Rami-Porta R, Bolejack V, Goldstraw P. The new tumor, node, and metastasis staging system. Semin Respir Crit Care Med 2011;32:44-51
59. Bach PB, Jett JR, Pastorino U, Tockmann M, Swensen SJ, Begg GB et al. Computed tomography screening and lung cancer outcomes. JAMA 2007;297:953-61
60. Veronesi G, Bellomi M, Mulshine JL, Pelosi G, Scanagatta P, Panganelli G et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008;61:340-9
61. Asamura H, Suzuki K, Watanabe S, Matsuno Y, Maeshima A, Tsuchiya R et al. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 2003;76:1016-22
62. Altorki NK, Yip R, Hanaoka Bauer T, Aye R, Kohman L et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg 2014;147:754-62
63. Stiles BM1, Altorki NK. Screening for lung cancer: challenges for the thoracic surgeon. Surg Oncol Clin N Am 2011;20:619-35
64. Gamarra F, Bofetta P, De Ruysscher D, Felip E, Gaga M, Grigoriu B et al. Thoracic oncology HERMES syllabus: setting the basis for thoracic oncology training in Europe. Eur Respir J 2013;42:568-71
65. Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015;16:630-7
66. van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren R, de Koning HJ. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J 2011;38:154-61
67. International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71
68. http://seer. cancer. gov/statfacts/html/lungb. html (4 October 2016, date last accessed)
69. Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli Bertoloffi R et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer a cohort study. Ann Intern Med 2012;157:776-84
70. Prasad V, Cifu A. Ending Medical Reversal: Improving Outcomes, Saving Lives. Baltimore: Johns Hopkins University Press, 2015
71. Hillerdal G. Indolent lung cancers-time for a paradigm shift: a review. J Thorac Oncol 2008;3:208-11
72. Yan TD, Cao C, D'amico TA, Demmy TL, Demmy TL, He J, International VATS Lobectomy Consensus Group et al. Video-assisted thoracoscopic surgery lobectomy at 20 years: a consensus statement. Eur J Cardiothorac Surg 2014;45:633-9
73. Paul S, Altorki NK, Sheng S, Lee PC, Harpole DH, Onaitis MW et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS Database. J Thorac Cardiovasc Surg 2010;139:366-78
74. Burfeind W, Jaik N, Villamizar N, Toloza E, Harpole D, D'amico TAA, Cost M. Analysis of lobectomy: thoracoscopic vs. posterolateral thoracotomy. Eur J Cardiothorac Surg 2010;37:827-32
75. Berry MF, D'amico TA, Onaitis MW, Kelsey CR. Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy. Ann of Thorac Surg 2014;98:197-202
76. Park BJ, Melfi F, Mussi A, Maisonneuve P, Spaggiari L, Da Silva RK et al. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results. J Thorac Cardiovasc Surg 2012;143:383-9
77. Pardolesi A, Park B, Petrella F, Borri A, Gasparri R, Veronesi G. Robotic anatomic segmentectomy of the lung: technical aspects and initial results. Ann Thorac Surg 2012;94:929-34
78. Yang CF, D'amico TAl. Thoracoscopic segmentectomy for lung cancer. Ann Thorac Surg 2012;94:668-81
79. Russell PA, Wainer Z, Wright GM, Daniels M, Cohron M, Williams RA et al. Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:1496-504
80. Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012;30:1438-46
81. Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-64
82. Pass HI, Beerrt DG, Joseph S, Massion P. Biomarkers and molecular testing for early detection, diagnosis and therapeutic prediction of lung cancer. Thorac Surg Clin 2013;23:211-24
83. Asamura H, Hishida T, Suzuki K, Koike T, Nakamura K, Kusumoto M et al. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of the Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surgery 2013;146:24-30
84. Lim H-J, Ahn S, Lee KS, Shim YM, Woo S, Kim JH et al. Persistent pure ground-glass opacity lung nodules > 10mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest 2013;144:1291-9
85. Yankelevitz DF, Yip R, Smith JP, Liang M, Liu Y, Xu DM, International Early Lung Cancer Action Program Investigators Group et al. CT Screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds. Radiology 2015;277:555-64
86. Mimae T, Miyata Y, Tsutani Y, Mimura T, Nakayama H, Okumura H et al. What are the radiologic findings predictive of indolent lung adenocarcinoma? Jpn J Clin Oncol 2015;45:367-72
87. Detterbeck FC, Homer RJ. Approach to the ground-glass nodule. Clin Chest Med 2011;32:799-810
88. Tsutani Y, Miyata Y, Nakayama H. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. J Thorac Cardiovasc Surg 2012;143:607-12
89. Maeyashiki T, Suzuki K, Hattori A, Matsunaga T, Takamochi K, Oh S et al. The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer. Eur J Cardiothorac Surg 2013;43:915-8
90. Travis D, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB et al. The IASLC Lung Cancer Staging Project: proposals for coding T categories for adenocarcinoma in situ and minimally invasive adenocarcinoma, and for measurement of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM Classification of Lung Cancer. J Thorac Oncol 2016;11:1204-24
91. Chang B, Hwang JH, Choi YH, Chong MP, Kim H, Kwon OJ et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 2013;143:172-8
92. Gulati CM1, Schreiner AM, Libby DM, Port JL, Altorki NK, Gelbman BD. Outcomes of unresected ground-glass nodules with cytology suspicious for adenocarcinoma. J Thorac Oncol 2014;9:685-91
93. Kobayashi Y, Fukui T, Ito S, Usami N, Hatooka S, Yatabe Y et al. How long should small lung lesions of ground-glass opacity be followed? J Thorac Oncol 2013;8:309-14
94. Scholten ET, de Jong PA, de Hoop B, van Klaveren R, van Amelsvoortvan de Vorst S, Oudkerk M et al. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules? Eur Respir J 2015;45:765-73
95. Veronesi G, Travaini LL, Maisonneuve P, Rampinelli C, Bertolotti R, Spaggiari L et al. Positron emission tomography in the diagnostic workup of screening-detected lung nodules. Eur Respir J 2015;45:501-10
96. Lim E, Baldwin D, Beckles Duffy J, Enterisle J, Faivre-Finn C et al. Guidelines on the radical management of patients with lung cancer. Thorax 2010;65:iii1-27
97. Sakurai H, Asamura H. Sublobar resection for early-stage lung cancer. Transl Lung Cancer Res 2014;3:164-1872
98. Nakamura K, Sajii H, Nakajima R, Okada M, Asamura H, Shibata T et al. A phase III randomised trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/ WJOG4607). Jpn J Clin Oncol 2010;40:271-4
99. Petersen RH, Hansen HJ, Dirksen A, Pedersen JH. Lung cancer screening and video-assisted thoracic surgery. J Thorac Oncol 2012;7:1026-31
100. Van't Westeinde SC, Horeweg N, Leyn PD, Groend HJM, Lammerse JL, Weenink C et al. Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial. Eur J Cardio-Thoracic Surg 2012;42:420-9
101. Infante M, Cavuto S, Lutman FR, Pasvre E, Chiarenza M, Chiesa G et al. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 2015;191:1166-75
102. Kazerooni EA, Armstrong MR, Amorosa JK, Hernandez D, Liebscher LA, Nath H et al. ACR CT accreditation program and the lung cancer screening program designation. J Am College Radiol 2015;12:38-42
103. Falcoz PE, Puyraveau M, Rivera C, Bernard A, Massard G, Manny F et al. The impact of hospital and surgeon volume on the 30 day mortality of lung cancer surgery: a nation-based reappraisal. J Thorac Cardiovasc Surg 2014;148:841-8
104. Opitz I, Rocco G, Brunelli A, Varela G, Massard G, Weder W. Surgery versus SABR for resectable non-small cell lung cancer. Lancet Oncol 2015;16:372-3
105. McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am College Radiol 2015;12:273-6
106. Massard G, Rocco G, Venuta F. The European educational platform on thoracic surgery. J Thorac Dis 2014;6(Suppl 2): 276-83
107. Dietel M, Bubendorf L, Dingemans AM, Dooms C, Elmberger G, Garcia RC et al. Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group. Thorax 2016;71:177-84